ZEISS Medical Technology will showcase its latest innovations and digital technologies at AAO, including: Connected cataract ...

NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company, today announced the U.S. launch and commercial availability of clobetasol propionate ...

Exclusive Worldwide Licensing Agreement with Cella Therapeutics Adds an Array of New Chemical Entities to Visus’ Drug Pipeline Agreement with DelSiTech for Sustained Drug Delivery Platform Allows ...

– Eyenovia, Inc., a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in combination with its own drug-device therapeutic programs for mydriasis, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Smartlens – a clinical-stage ophthalmic technology company – announced has closed an oversubscribed $6.1 million Series A equity financing round to advance regulatory clearance for miLens, a novel, ...

Ophthalmic technology involves the use of advanced and digital devices to improve eye healthcare. This can be through improvements to diagnosis, tracking medical histories, the administration of eye ...

The eye is a unique window to overall health. Its associated medical imaging has great characteristics, such as being non-invasive, convenient, and rich in information, which offers significant ...

Chaomu Technology (Beijing) Co. Ltd. has raised nearly ¥100 million (US$14 million) in a series A+ round to develop its ophthalmic medical devices. The proceeds from the financing will be used for the ...

China-based Arctic Vision has signed an agreement for the acquisition of the ophthalmic device business of MDCO Technology. The transaction will integrate MDCO’s intraocular lens (IOL), implantable ...

SEATTLE--(BUSINESS WIRE)--Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world, today ...